LANG SHENG INVESTMENT
Lang Sheng Investment is a leading life science and big data investment firm in China committed to helping exceptional entrepreneurs build the next generation of great healthcare and big data companies. They invest across the healthcare and big data sectors with an emphasis on the venture stages of company development. With close to RMB600 million under management and the headquarters in Shanghai, Lang Sheng has built a team with strong investment expertise. Since the firm’s founding in 2010, they have invested in 23 companies in the life science and big data companies in China.
LANG SHENG INVESTMENT
Social Links:
Industry:
Financial Services Venture Capital
Founded:
2010-01-01
Status:
Active
Contact:
(8621) 5237-9025
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Content Delivery Network Font Awesome Nginx JsDelivr OSS CDN Lorem Ipsum
Similar Organizations
Bridges Israel
Bridges Israel is an impact investment fund.
SDIC Capital
SDIC Capital is an investment firm based in China.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-07-31 | Hinova Pharma | Lang Sheng Investment investment in Series B - Hinova Pharma | 40 M USD |
2019-05-23 | Yuntai Network | Lang Sheng Investment investment in Series B - Yuntai Network | 100 M CNY |
2019-04-27 | Yao123.com | Lang Sheng Investment investment in Series B - Yao123.com | 300 M CNY |
2019-02-26 | Suochen Information Technology | Lang Sheng Investment investment in Series B - Suochen Information Technology | N/A |
2019-01-10 | Jekun Auto | Lang Sheng Investment investment in Series B - Jekun Auto | 14.8 M USD |
2018-08-07 | Moviebook | Lang Sheng Investment investment in Series D - Moviebook | 1.36 B CNY |
2018-07-20 | Suochen Information Technology | Lang Sheng Investment investment in Series A - Suochen Information Technology | N/A |
2018-06-29 | Svision | Lang Sheng Investment investment in Series A - Svision | 3.78 M USD |
2018-06-12 | Abmart | Lang Sheng Investment investment in Series B - Abmart | 20 M CNY |
2018-04-11 | ImmuneOnco Biopharma | Lang Sheng Investment investment in Series A - ImmuneOnco Biopharma | 15.8 M USD |